Login to Your Account



Takeda Tempted by Fate; Adds to Regenerative Medicine Effort

By Jennifer Boggs


Wednesday, May 11, 2011
Fate Therapeutics Inc.'s approach to stem cell therapy – developing small-molecule drugs aimed at modulating adult stem cells – has attracted another investor: Takeda Ventures Inc.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription